CGON
Price:
$72.185
Market Cap:
$6.37B
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent;...[Read more]
Industry
Biotechnology
IPO Date
2024-01-25
Stock Exchange
NASDAQ
Ticker
CGON
According to CG Oncology Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -30.98. This represents a change of 68.61% compared to the average of -18.37 of the last 4 quarters.
The mean historical PE Ratio of CG Oncology Inc. over the last ten years is -53.16. The current -30.98 PE Ratio has changed 5.73% with respect to the historical average. Over the past ten years (40 quarters), CGON's PE Ratio was at its highest in in the June 2025 quarter at -12.04. The PE Ratio was at its lowest in in the December 2022 quarter at -71.48.
Average
-53.16
Median
-36.44
Minimum
-132.75
Maximum
-19.96
Discovering the peaks and valleys of CG Oncology Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -19.96
Minimum Annual Increase = -57.58%
Minimum Annual PE Ratio = -132.75
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -19.96 | -1.86% |
| 2024 | -20.34 | -44.18% |
| 2023 | -36.44 | -35.29% |
| 2022 | -56.32 | -57.58% |
The current PE Ratio of CG Oncology Inc. (CGON) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-25.58
5-year avg
-53.16
10-year avg
-53.16
CG Oncology Inc.’s PE Ratio is less than Celcuity Inc. (-23.93), less than Ascentage Pharma Group International (-8.17), less than Centessa Pharmaceuticals plc (-22.75), less than Apogee Therapeutics, Inc. (-30.98), less than Xenon Pharmaceuticals Inc. (-13.68), greater than Travere Therapeutics, Inc. (-139.00), less than Ultragenyx Pharmaceutical Inc. (-4.30), less than Legend Biotech Corporation (-14.22), less than Disc Medicine, Inc. (-11.73), greater than Tarsus Pharmaceuticals, Inc. (-52.81),
| Company | PE Ratio | Market cap |
|---|---|---|
| -23.93 | $4.54B | |
| -8.17 | $1.56B | |
| -22.75 | $6.27B | |
| -30.98 | $8.30B | |
| -13.68 | $6.22B | |
| -139.00 | $5.82B | |
| -4.30 | $2.47B | |
| -14.22 | $3.58B | |
| -11.73 | $2.97B | |
| -52.81 | $2.59B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CG Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CG Oncology Inc.'s PE Ratio?
How is the PE Ratio calculated for CG Oncology Inc. (CGON)?
What is the highest PE Ratio for CG Oncology Inc. (CGON)?
What is the 3-year average PE Ratio for CG Oncology Inc. (CGON)?
What is the 5-year average PE Ratio for CG Oncology Inc. (CGON)?
How does the current PE Ratio for CG Oncology Inc. (CGON) compare to its historical average?